Different Effects of Farrerol on an OVA-Induced Allergic Asthma and LPS-induced Acute Lung Injury
Open Access
- 26 April 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (4), e34634
- https://doi.org/10.1371/journal.pone.0034634
Abstract
Farrerol, isolated from rhododendron, has been shown to have the anti-bacterial activity, but no details on the anti-inflammatory activity. We further evaluated the effects of this compound in two experimental models of lung diseases. For the asthma model, female BALB/c mice were challenged with ovalbumin (OVA), and then treated daily with farrerol (20 and 40 mg/kg, ip) as a therapeutic treatment from day 22 to day 26 post immunization. To induce acute lung injury, female BALB/c mice were injected intranasally with LPS and treated with farrerol (20 and 40 mg/kg, i.p.) 1 h prior to LPS stimulation. Inflammation in the two different models was determined using ELISA, histology, real-time PCR and western blot. Farrerol significantly regulated the phenotype challenged by OVA, like cell number, Th1 and Th2 cytokines levels in the BALF, the OVA-specific IgE level in the serum, goblet cell hyperplasia in the airway, airway hyperresponsiveness to inhaled methacholine and mRNA expression of chemokines and their receptors. Furthermore, farrerol markedly attenuated the activation of phosphorylation of Akt and nuclear factor-κB (NF-κB) subunit p65 both in vivo and in vitro. However, farrerol has no effect on the acute lung injury model. Our finding demonstrates that the distinct anti-inflammatory effect of farrerol in the treatment of asthma acts by inhibiting the PI3K and NF-κB pathway.Keywords
This publication has 35 references indexed in Scilit:
- Apigenin protects ovalbumin-induced asthma through the regulation of GATA-3 geneInternational Immunopharmacology, 2009
- Phosphoinositide 3‐kinase δ inhibitor as a novel therapeutic agent in asthmaRespirology, 2008
- Nuclear Factor-κB Activation in Airway Epithelium Induces Inflammation and HyperresponsivenessAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthmaEuropean Journal of Pharmacology, 2008
- 7. Immunologic lung diseaseJournal of Allergy and Clinical Immunology, 2008
- Glucocorticoid receptor action in beneficial and side effects of steroid therapy: Lessons from conditional knockout miceMolecular and Cellular Endocrinology, 2007
- Glycogen Synthase Kinase-3β Inhibition Attenuates Asthma in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2007
- PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?Nature Reviews Immunology, 2007
- Targeting Mitogen-Activated Protein Kinases for AsthmaCurrent Drug Targets, 2006
- Transcription Factors in Asthma: Are Transcription Factors a New Target for Asthma Therapy?Current Drug Targets, 2006